XYOSTED Trademark

Trademark Overview

On Friday, September 30, 2016, a trademark application was filed for XYOSTED with the United States Patent and Trademark Office. The USPTO has given the XYOSTED trademark a serial number of 87190011. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, August 22, 2025. This trademark is owned by Antares Pharma Inc.. The XYOSTED trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of testosterone deficiency; pharmaceutical preparations for the treatment of hypogonadism; pharmaceutical preparations, namely, testosterone; pharmaceutical preparations, namely, injectable testosterone
xyosted

General Information

Serial Number87190011
Word MarkXYOSTED
Filing DateFriday, September 30, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, August 22, 2025
Registration Number5740198
Registration DateTuesday, April 30, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 21, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of testosterone deficiency; pharmaceutical preparations for the treatment of hypogonadism; pharmaceutical preparations, namely, testosterone; pharmaceutical preparations, namely, injectable testosterone

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 6, 2016
Primary Code005
First Use Anywhere DateSaturday, December 1, 2018
First Use In Commerce DateSaturday, December 1, 2018

Trademark Owner History

Party NameAntares Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEwing, NJ 08628
Party NameAntares Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEwing, NJ 08628
Party NameAntares Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEwing, NJ 08628

Trademark Events

Event DateEvent Description
Thursday, October 6, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 9, 2017ASSIGNED TO EXAMINER
Tuesday, February 21, 2017PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 4, 2016NEW APPLICATION ENTERED
Monday, January 9, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 1, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 21, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 4, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, September 4, 2018SOU EXTENSION 3 FILED
Tuesday, September 4, 2018SOU EXTENSION 3 GRANTED
Thursday, September 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 4, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, October 4, 2017SOU EXTENSION 1 FILED
Wednesday, October 4, 2017SOU EXTENSION 1 GRANTED
Friday, October 6, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 2, 2018SOU TEAS EXTENSION RECEIVED
Monday, April 2, 2018SOU EXTENSION 2 FILED
Monday, April 2, 2018SOU EXTENSION 2 GRANTED
Wednesday, April 4, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 11, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, February 13, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 20, 2019USE AMENDMENT FILED
Wednesday, February 13, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, March 20, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 26, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 26, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 28, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 30, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, March 21, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 21, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 27, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 30, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, April 17, 2025TEAS SECTION 8 & 15 RECEIVED
Friday, August 22, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 22, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, August 22, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, March 21, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

xyosted preparations pharmaceutical testosterone namely treatment injectable hypogonadism deficiency